Overview

Sugammadex Dose Finding Under Two Years Old

Status:
NOT_YET_RECRUITING
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
This is a prospective dose-finding study of sugammadex for conventional reversal of rocuronium-induced neuromuscular blockade in children under two years of age. This study will explore 50% effective dose and 95% effective dose of sugammadex for reversal of neuromuscular blockade in less than two minutes under biased coin up-and-down method.
Phase:
PHASE2
Details
Lead Sponsor:
Sang-Hwan Ji
Treatments:
Sugammadex